Capital Impact Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History

Capital Impact Advisors’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-430	Closed	-$310K	–	221
2022 Q4	$310K	Sell	430 -17	-4%	-$12.3K	0.3%	143
2022 Q3	$308K	Sell	447 -58	-11%	-$40K	0.31%	138
2022 Q2	$299K	Sell	505 -746	-60%	-$442K	0.28%	158
2022 Q1	$874K	Sell	1,251 -701	-36%	-$490K	0.64%	57
2021 Q4	$1.23M	Sell	1,952 -4,615	-70%	-$2.92M	0.85%	44
2021 Q3	$3.97M	Buy	6,567 +3,344	+104%	+$2.02M	1.57%	9
2021 Q2	$1.8M	Buy	3,223 +1,022	+46%	+$571K	0.58%	73
2021 Q1	$1.04M	Sell	2,201 -1,914	-47%	-$905K	0.36%	88
2020 Q4	$1.99M	Hold	4,115	–	–	0.49%	81
2020 Q3	$2.3M	Sell	4,115 -1,500	-27%	-$839K	0.68%	69
2020 Q2	$3.5M	Sell	5,615 -1,459	-21%	-$910K	1.17%	21
2020 Q1	$3.45M	Hold	7,074	–	–	1.45%	14
2019 Q4	$2.66M	Hold	7,074	–	–	0.93%	23
2019 Q3	$1.93M	Sell	7,074 -508	-7%	-$139K	0.74%	77
2019 Q2	$2.36M	Hold	7,582	–	–	0.86%	28
2019 Q1	$2.75M	Hold	7,582	–	–	1.22%	12
2018 Q4	$2.75M	Hold	7,582	–	–	1.17%	13
2018 Q3	$3.08M	Hold	7,582	–	–	1.06%	16
2018 Q2	$2.59M	Hold	7,582	–	–	0.96%	21
2018 Q1	$2.61M	Buy	7,582 +3,132	+70%	+$1.08M	1.07%	20
2017 Q4	$1.67M	Hold	4,450	–	–	0.72%	50
2017 Q3	$1.99M	Sell	4,450 -1,495	-25%	-$669K	0.89%	25
2017 Q2	$2.92M	Hold	5,945	–	–	1.33%	9
2017 Q1	$2.3M	Buy	5,945 +2,175	+58%	+$843K	0.92%	14
2016 Q4	$1.38M	Hold	3,770	–	–	0.57%	37
2016 Q3	$1.52M	Hold	3,770	–	–	0.65%	24
2016 Q2	$1.32M	Buy	3,770 +1,000	+36%	+$349K	0.62%	29
2016 Q1	$998K	Sell	2,770 -725	-21%	-$261K	0.48%	57
2015 Q4	$1.9M	Hold	3,495	–	–	0.91%	8
2015 Q3	$1.63M	Hold	3,495	–	–	0.83%	29
2015 Q2	$1.78M	Sell	3,495 -1,300	-27%	-$663K	0.81%	20
2015 Q1	$2.16M	Sell	4,795 -5,347	-53%	-$2.41M	0.99%	9
2014 Q4	$4.16M	Hold	10,142	–	–	1.96%	5
2014 Q3	$2.05M	Buy	10,142 +5,672	+127%	+$1.14M	2.7%	9
2014 Q2	$1.26M	Hold	4,470	–	–	0.95%	49
2014 Q1	$1.34M	Hold	4,470	–	–	1.08%	42
2013 Q4	$1.23M	Buy	+4,470	New	+$1.23M	0.99%	59